119 related articles for article (PubMed ID: 9558061)
1. Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology.
Hemmer B; Vergelli M; Gran B; Ling N; Conlon P; Pinilla C; Houghten R; McFarland HF; Martin R
J Immunol; 1998 Apr; 160(8):3631-6. PubMed ID: 9558061
[TBL] [Abstract][Full Text] [Related]
2. Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands.
Dressel A; Chin JL; Sette A; Gausling R; Höllsberg P; Hafler DA
J Immunol; 1997 Nov; 159(10):4943-51. PubMed ID: 9366420
[TBL] [Abstract][Full Text] [Related]
3. A molecular basis for how a single TCR interfaces multiple ligands.
Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
[TBL] [Abstract][Full Text] [Related]
5. Possibilities and limitations in the rational design of modified peptides for T cell mediated immunotherapy.
de Haan EC; Moret EE; Wagenaar-Hilbers JP; Liskamp RM; Wauben MH
Mol Immunol; 2005 Feb; 42(3):365-73. PubMed ID: 15589325
[TBL] [Abstract][Full Text] [Related]
6. Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99).
Vergelli M; Hemmer B; Utz U; Vogt A; Kalbus M; Tranquill L; Conlon P; Ling N; Steinman L; McFarland HF; Martin R
Eur J Immunol; 1996 Nov; 26(11):2624-34. PubMed ID: 8921948
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of molecular mimicry.
Wucherpfennig KW
J Autoimmun; 2001 May; 16(3):293-302. PubMed ID: 11334495
[TBL] [Abstract][Full Text] [Related]
8. Limited plasticity in T cell recognition of modified T cell receptor contact residues in MHC class II bound peptides.
de Haan EC; Wagenaar-Hilbers JP; Liskamp RM; Moret EE; Wauben MH
Mol Immunol; 2005 Feb; 42(3):355-64. PubMed ID: 15589324
[TBL] [Abstract][Full Text] [Related]
9. T cell receptor crossreactivity as a general property of T cell recognition.
Wucherpfennig KW
Mol Immunol; 2004 Feb; 40(14-15):1009-17. PubMed ID: 15036904
[TBL] [Abstract][Full Text] [Related]
10. Alterations in TCR-MHC contacts subsequent to cross-recognition of class I MHC and singly substituted peptide variants.
Ono T; DiLorenzo TP; Wang F; Kalergis AM; Nathenson SG
J Immunol; 1998 Nov; 161(10):5454-63. PubMed ID: 9820521
[TBL] [Abstract][Full Text] [Related]
11. Structural features of autoreactive TCR that determine the degree of degeneracy in peptide recognition.
Hausmann S; Martin M; Gauthier L; Wucherpfennig KW
J Immunol; 1999 Jan; 162(1):338-44. PubMed ID: 9886404
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity. I. Use of peptide libraries to identify epitopes that activate clonotypic CD4+ T cells and induce T cell responses to native peptide ligands.
Wilson DB; Pinilla C; Wilson DH; Schroder K; Boggiano C; Judkowski V; Kaye J; Hemmer B; Martin R; Houghten RA
J Immunol; 1999 Dec; 163(12):6424-34. PubMed ID: 10586032
[TBL] [Abstract][Full Text] [Related]
13. Autoantigen-responsive T cell clones demonstrate unfocused TCR cross-reactivity toward multiple related ligands: implications for autoimmunity.
Anderson AC; Waldner H; Turchin V; Jabs C; Prabhu Das M; Kuchroo VK; Nicholson LB
Cell Immunol; 2000 Jun; 202(2):88-96. PubMed ID: 10896768
[TBL] [Abstract][Full Text] [Related]
14. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
Geluk A; van Meijgaarden KE; Roep BO; Ottenhoff TH
J Autoimmun; 1998 Aug; 11(4):353-61. PubMed ID: 9776713
[TBL] [Abstract][Full Text] [Related]
15. In the normal repertoire of CD4+ T cells, a single class II MHC/peptide complex positively selects TCRs with various antigen specificities.
Chmielowski B; Muranski P; Ignatowicz L
J Immunol; 1999 Jan; 162(1):95-105. PubMed ID: 9886374
[TBL] [Abstract][Full Text] [Related]
16. Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. Implications for thymic education and autoimmunity.
Bhardwaj V; Kumar V; Geysen HM; Sercarz EE
J Immunol; 1993 Nov; 151(9):5000-10. PubMed ID: 7691962
[TBL] [Abstract][Full Text] [Related]
17. Modification of peptide interaction with MHC creates TCR partial agonists.
Ryan KR; McNeil LK; Dao C; Jensen PE; Evavold BD
Cell Immunol; 2004 Jan; 227(1):70-8. PubMed ID: 15051516
[TBL] [Abstract][Full Text] [Related]
18. Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures.
Hausmann S; Biddison WE; Smith KJ; Ding YH; Garboczi DN; Utz U; Wiley DC; Wucherpfennig KW
J Immunol; 1999 May; 162(9):5389-97. PubMed ID: 10228016
[TBL] [Abstract][Full Text] [Related]
19. Serial TCR engagement and down-modulation by peptide:MHC molecule ligands: relationship to the quality of individual TCR signaling events.
Itoh Y; Hemmer B; Martin R; Germain RN
J Immunol; 1999 Feb; 162(4):2073-80. PubMed ID: 9973480
[TBL] [Abstract][Full Text] [Related]
20. Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells.
Vergelli M; Hemmer B; Kalbus M; Vogt AB; Ling N; Conlon P; Coligan JE; McFarland H; Martin R
J Immunol; 1997 Apr; 158(8):3746-52. PubMed ID: 9103439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
